.Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B01A_AntithromboticAgents.B01AB09_Danaparoid.Danaparoid .Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B01A_AntithromboticAgents.B01AB09_Danaparoid.Danaparoid| name: | Danaparoid |
| ATC code: | B01AB09 | route: | subcutaneous |
| n-compartments | 2 |
Danaparoid is a low molecular weight heparinoid anticoagulant, composed of a mixture of glycosaminoglycans, primarily used as an alternative anticoagulant in patients with heparin-induced thrombocytopenia (HIT). It is administered parenterally. Though previously widely used, its availability has become limited in some regions due to regulatory and supply issues.
Pharmacokinetics in healthy adult volunteers and patients; based on published data of anti-factor Xa activity after intravenous and subcutaneous administration.